| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Ganciclovir | 1.00 | No resistance | Recombinant | Details | Phenotypic evaluation of previously uncharacterized cytomegalovirus DNA polymerase sequence variants detected in a valganciclovir treatment trial. (Apr 2014) | ||
| Cidofovir | 1.00 | No resistance | Recombinant | Details | Phenotypic evaluation of previously uncharacterized cytomegalovirus DNA polymerase sequence variants detected in a valganciclovir treatment trial. (Apr 2014) | ||
| Foscarnet | 1.00 | No resistance | Recombinant | Details | Phenotypic evaluation of previously uncharacterized cytomegalovirus DNA polymerase sequence variants detected in a valganciclovir treatment trial. (Apr 2014) |
| Mutant | Resistances |
|---|---|
| A543V |
Cidofovir:
|
| A543V |
Cidofovir:
|
| A543V |
Foscarnet:
|
| A543V |
Ganciclovir:
|